Adial is a Virginia-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of addiction and related disorders.
Business Model:
Revenue: $10M
Employees: 11-50
Address: 1180 Seminole Trail
City: Charlottesville
State: VA
Zip: 22901
Country: US
Adial is a Virginia-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of addiction and related disorders.
Contact Phone:
+14344229800
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/27/2018
IPO Valuation:
$33M
Ticker Symbol:
ADIL
IPO Price:
$5/share
Amount Raised:
$8M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2013 | Venture Round | $2.6M | 3/2021 | Post-IPO Equity | 1 | $2.1M |
Keystone Capital Partners Keystone Capital Partners |
7/2021 | Private Placement | $5M | 7/2021 | Post-IPO Equity | 3 | $5M |
Bespoke Growth Partners Keystone Capital Partners Richard Gilliam Bespoke Growth Partners Keystone Capital Partners Richard Gilliam |
2/2021 | Post-IPO Debt | $1.4M | 9/2020 | Post-IPO Equity | $500k | 5/2017 | Debt Financing | $287.5k | 11/2020 | Post-IPO Equity | $295.8k | 12/2021 | Private Placement | $720k | 3/2011 | Venture Round | $4.1M | 2/2022 | Post-IPO Equity | $10M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|